• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者报告的多种药物反应:临床特征和挑战试验结果。

Patient-reported multiple drug reactions: clinical profile and results of challenge testing.

机构信息

Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, 110 029, India.

出版信息

Indian J Dermatol Venereol Leprol. 2010 Jul-Aug;76(4):382-6. doi: 10.4103/0378-6323.66587.

DOI:10.4103/0378-6323.66587
PMID:20657119
Abstract

BACKGROUND

Some patients report hypersensitivity reactions to many drugs making it difficult to prescribe medications when they fall ill.

AIM

To describe the clinical profile of multiple drug hypersensitivity and the results of challenge testing in a large teaching hospital.

METHODS

We performed a five-year retrospective review of the records of patients who complained of reactions to two or more unrelated drugs and avoided medication because of a fear of developing reactions. Oral challenge testing was carried out in hospital with drugs suspected by the patient to cause reactions and/or commonly prescribed medications. A positive reaction was diagnosed when symptoms and signs resembled previously experienced episodes and there was no such reaction with placebo.

RESULTS

Twenty three patients (aged 14-65 years; 19 females) underwent challenge testing. Their complaints had been present for 1-30 years, with 2-40 drug reaction episodes reported. Antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs) were most commonly implicated, and urticaria/angioedema were the most often reported manifestations. The patients underwent 3-27 challenges with 1-24 drugs. Three had positive challenge reactions with various NSAIDs, 13 developed symptoms and signs that were judged not to be true reactions, and 7 had no reactions. None of our patients qualified for a diagnosis of true multiple drug hypersensitivity.

CONCLUSION

Patients who believe they are allergic to multiple, pharmacologically unrelated drugs are usually mistaken. Challenge testing is a reliable way of demonstrating this and providing patients with a list of safe drugs.

摘要

背景

一些患者报告对多种药物过敏,导致他们生病时难以开处方。

目的

描述大型教学医院中多位药物过敏的临床特征和挑战测试结果。

方法

我们对因担心发生反应而避免用药的、报告对两种或多种无关药物过敏的患者的记录进行了为期五年的回顾性研究。在医院对患者怀疑引起反应的药物和/或常用药物进行口服挑战测试。当症状和体征与之前经历过的发作相似且与安慰剂无此类反应时,诊断为阳性反应。

结果

23 名患者(年龄 14-65 岁;19 名女性)接受了挑战测试。他们的抱怨已经存在 1-30 年,报告了 2-40 次药物反应发作。抗生素和非甾体抗炎药(NSAIDs)最常被牵连,荨麻疹/血管性水肿是最常报告的表现。患者接受了 3-27 次挑战测试,涉及 1-24 种药物。有 3 人对各种 NSAIDs 有阳性挑战反应,13 人出现被判断为非真实反应的症状和体征,7 人无反应。我们的患者均不符合真正的多位药物过敏诊断。

结论

认为自己对多种药物过敏的患者通常是错误的。挑战测试是证明这一点并为患者提供安全药物清单的可靠方法。

相似文献

1
Patient-reported multiple drug reactions: clinical profile and results of challenge testing.患者报告的多种药物反应:临床特征和挑战试验结果。
Indian J Dermatol Venereol Leprol. 2010 Jul-Aug;76(4):382-6. doi: 10.4103/0378-6323.66587.
2
Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.亚洲特应性体质的年轻儿童对非甾体抗炎药交叉反应性超敏反应中血管性水肿和荨麻疹的早期表现
Pediatrics. 2005 Nov;116(5):e675-80. doi: 10.1542/peds.2005-0969. Epub 2005 Oct 17.
3
Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.对乙酰氨基酚(扑热息痛)和尼美舒利有皮肤不良反应的患者使用塞来昔布的安全性,无论是否与常见非甾体抗炎药相关。
Eur Ann Allergy Clin Immunol. 2005 Feb;37(2):50-3.
4
Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period.疑似皮肤药物不良反应患者的口服激发试验:25年间784例患者的研究结果
Acta Derm Venereol. 2005;85(6):491-6. doi: 10.1080/00015550510042859.
5
[Urticaria--angioedema induced by non-steroidal anti-inflammatory analgesics].[非甾体类抗炎镇痛药诱发的荨麻疹 - 血管性水肿]
Allergol Immunopathol (Madr). 1984 May-Jun;12(3):179-88.
6
Cutaneous reactions to non-steroidal anti-inflammatory drugs.非甾体抗炎药的皮肤反应
J Drugs Dermatol. 2011 Oct;10(10):1160-7.
7
Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis.非甾体类抗炎药诱导的荨麻疹、血管性水肿和过敏反应的口服药物挑战。
Intern Med J. 2012 Jun;42(6):665-71. doi: 10.1111/j.1445-5994.2011.02601.x.
8
Floctafenine: a valid alternative in patients with adverse reactions to nonsteroidal anti-inflammatory drugs.氟考丁宁:对非甾体抗炎药有不良反应患者的有效替代药物。
Ann Allergy Asthma Immunol. 1997 Jan;78(1):74-8. doi: 10.1016/S1081-1206(10)63376-5.
9
Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance.临床病史在诊断 NSAIDs 交叉不耐受所致荨麻疹/血管性水肿中的价值。
Clin Exp Allergy. 2013 Jan;43(1):85-91. doi: 10.1111/cea.12013.
10
Oral drug provocation test to generate a list of safe drugs: experience with 100 patients.口服药物激发试验生成安全药物清单:100 例患者的经验。
Indian J Dermatol Venereol Leprol. 2012 Sep-Oct;78(5):595-8. doi: 10.4103/0378-6323.100563.

引用本文的文献

1
Characterization, epidemiology and risk factors of multiple drug allergy syndrome and multiple drug intolerance syndrome: A systematic review.多重药物过敏综合征和多重药物不耐受综合征的特征、流行病学及危险因素:一项系统综述
Clin Transl Allergy. 2022 Aug 22;12(8):e12190. doi: 10.1002/clt2.12190. eCollection 2022 Aug.
2
Multiple Drug Intolerance Syndrome: An Underreported Distinct Clinical Entity.多种药物不耐受综合征:一种报告不足的独特临床实体。
Curr Clin Pharmacol. 2019;14(2):84-90. doi: 10.2174/1574884713666181112125714.
3
Cutaneous adverse drug reactions in Indian population: A systematic review.
印度人群中的皮肤药物不良反应:一项系统综述。
Indian Dermatol Online J. 2014 Dec;5(Suppl 2):S76-86. doi: 10.4103/2229-5178.146165.
4
Evaluation of antibiotic allergy: the role of skin tests and drug challenges.抗生素过敏评估:皮肤试验和药物激发试验的作用。
Curr Allergy Asthma Rep. 2014 Sep;14(9):459. doi: 10.1007/s11882-014-0459-z.